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ABSTRACT:  
 
BACKGROUND 
First proposed by Khachaturian in 1994, the calcium hypothesis postulates that 
sustained disturbance of intracellular calcium is the leading cause of neurodegenerative 
disorders. Studies showing alteration in calcium signaling in both sporadic and familial 
Alzheimer’s disease (AD) support this hypothesis. Intracellular calcium signaling is tightly 
regulated in time, intensity, and space, and is responsible for a variety of neuronal functions. 
Calcium influx from the extracellular environment modulates calcium levels, as do intracellular 
stores in the endoplasmic reticulum. The focus of this study was to test various calcium related 
genes in both monocytes and neuronal cells. Previous studies have shown that cells infected with 
Chlamydia pneumoniae (Cpn) exhibit altered protein processing, such as amyloid and tau 
modification, consistent with those found in AD. We expect to see significant alterations in 
calcium genes, as well as their protein products in Cpn infected cells. Every calcium gene has a 
unique function in the cell. Determining which genes are up or down regulated following 
infection may provide insight into how the neurodegeneration process observed in AD is 
initiated by Cpn infections. 
 
METHODS 
 Using the AR39 strain of Cpn at a MOI of one, both THP-1 monocytes and SKNMC 
(ATCC) neuronal cells were infected for 48 hours. Cells were analyzed using Real-time PCR 
microarrays (SABiosciences) for calcium related genes. Protein regulation was recorded using 
fast western blotting with three calcium protein antibodies.  Monocytes and neuronal cells were 
also labeled with 61C75 directly conjugated antibody to FITC (Fitzgerald, Inc.) for verification 
of infection with Cpn.  
 
RESULTS 
 Calcium genes with a two fold increase or decrease in Cpn-infected cells were noted. 
Twelve genes exhibited this behavior in both THP-1 and SKNMC cells. Of the twelve genes, 
S100A12 (S100 Calcium Binding Protein) had the greatest degree of up-regulation (approx. 35x) 
in THP-1 monocytes. NF-1 (Neurofibromin-1) had the highest degree of down-regulation in both 
THP-1 and SKNMC cells. CHGA (Chromogranin A) was up-regulated two fold in THP-1 cells 
and down-regulated two fold in SKNMC. In western blot protein analysis, S100A12 was up-
regulated in SKNMC cells and showed no protein product in THP-1 monocytes; NF-1 was up-
regulated in both THP-1 and SKNMC cells; and CHGA was down-regulated in both THP-1 and 
SKNMC cells. Western blot analysis was confirmed by immunofluorescence for NF-1 and 
S100A12 in SKMNC neuronal cells. 
 
CONCLUSIONS 
Our data suggest that Cpn alters calcium-related gene regulation and levels of protein products of 
at least three calcium genes, perhaps to maintain an environment beneficial to its survival. These 
changes may be associated with the disturbances in intracellular calcium previously observed in 
AD, and may elucidate how Cpn may affect normal cellular processes, thereby contributing to 
the neuropathology seen in AD. 
 
